Segment information - Information by Segment on Current Cost of Supplies Basis (Details) - USD ($) $ in Millions |
12 Months Ended |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Disclosure of operating segments [line items] |
|
|
|
Revenue |
$ 284,312
|
$ 316,620
|
$ 381,314
|
Share of profit/(loss) of joint ventures and associates (CCS basis) |
2,967
|
3,758
|
3,930
|
Interest and other income, of which: |
1,724
|
2,838
|
915
|
Interest income |
2,372
|
2,313
|
1,046
|
Net (losses)/gains on sale and revaluation of non-current assets and businesses |
(288)
|
257
|
642
|
Other |
(360)
|
268
|
(773)
|
Total expenditure |
259,107
|
290,556
|
321,386
|
Production and manufacturing expenses |
23,379
|
25,240
|
25,518
|
Selling, distribution and administrative expenses |
12,439
|
13,433
|
12,883
|
Research and development expenses |
1,099
|
1,287
|
1,075
|
Exploration expenses |
2,411
|
1,750
|
1,712
|
Depreciation, depletion and amortisation charge, of which: |
26,872
|
31,290
|
18,529
|
Impairment losses |
4,502
|
8,947
|
2,313
|
Impairment reversals |
(333)
|
(762)
|
(6,177)
|
Interest expense |
4,787
|
4,673
|
3,181
|
Taxation charge/(credit) (CCS basis) |
13,492
|
13,194
|
21,497
|
Impairment losses on property, plant and equipment |
3,673
|
8,182
|
1,799
|
Goodwill |
510
|
635
|
361
|
Intangible assets other than goodwill |
319
|
130
|
153
|
Reversal of impairment loss recognised in profit or loss, property, plant and equipment |
333
|
627
|
6,177
|
Intangible assets other than goodwill |
0
|
135
|
0
|
CCS earnings |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Taxation charge/(credit) (CCS basis) |
91
|
203
|
(444)
|
CCS earnings |
16,792
|
20,281
|
41,562
|
Inter-segment |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
96,944
|
105,612
|
132,682
|
Operating segments |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Third-party and inter-segment purchases (CCS basis) |
284,676
|
317,680
|
392,884
|
Total expenditure |
36,917
|
39,960
|
39,476
|
Production and manufacturing expenses |
23,379
|
25,240
|
25,518
|
Selling, distribution and administrative expenses |
12,439
|
13,433
|
12,883
|
Research and development expenses |
1,099
|
1,287
|
1,075
|
Exploration expenses |
2,411
|
1,750
|
1,712
|
Depreciation, depletion and amortisation charge, of which: |
26,872
|
31,290
|
18,529
|
Impairment losses |
4,502
|
8,947
|
2,313
|
Impairment reversals |
(333)
|
(762)
|
(6,177)
|
Interest expense |
4,787
|
4,673
|
3,181
|
Integrated Gas |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
37,290
|
37,645
|
54,751
|
Share of profit/(loss) of joint ventures and associates (CCS basis) |
1,931
|
1,951
|
1,219
|
Interest and other income, of which: |
48
|
137
|
(714)
|
Interest income |
8
|
6
|
43
|
Net (losses)/gains on sale and revaluation of non-current assets and businesses |
(100)
|
(22)
|
101
|
Other |
140
|
153
|
(858)
|
Taxation charge/(credit) (CCS basis) |
3,144
|
2,806
|
5,901
|
Reversal of impairment loss recognised in profit or loss, property, plant and equipment |
|
325
|
3,449
|
Integrated Gas | CCS earnings |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
CCS earnings |
9,590
|
7,057
|
22,221
|
Integrated Gas | Inter-segment |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
8,715
|
11,560
|
18,412
|
Integrated Gas | Operating segments |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Third-party and inter-segment purchases (CCS basis) |
24,055
|
27,356
|
37,785
|
Total expenditure |
4,442
|
4,809
|
5,226
|
Production and manufacturing expenses |
4,153
|
4,529
|
4,907
|
Selling, distribution and administrative expenses |
164
|
154
|
207
|
Research and development expenses |
125
|
126
|
112
|
Exploration expenses |
414
|
216
|
240
|
Depreciation, depletion and amortisation charge, of which: |
6,150
|
8,903
|
2,211
|
Impairment losses |
564
|
3,472
|
115
|
Impairment reversals |
(9)
|
(324)
|
(3,449)
|
Interest expense |
189
|
146
|
84
|
Upstream |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
6,606
|
6,475
|
8,352
|
Share of profit/(loss) of joint ventures and associates (CCS basis) |
1,189
|
768
|
2,111
|
Interest and other income, of which: |
609
|
671
|
726
|
Interest income |
18
|
27
|
22
|
Net (losses)/gains on sale and revaluation of non-current assets and businesses |
89
|
209
|
437
|
Other |
502
|
435
|
267
|
Taxation charge/(credit) (CCS basis) |
9,387
|
8,380
|
14,078
|
Impairment losses on property, plant and equipment |
|
|
320
|
Reversal of impairment loss recognised in profit or loss, property, plant and equipment |
|
203
|
2,504
|
Upstream | CCS earnings |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
CCS earnings |
7,772
|
8,540
|
16,258
|
Upstream | Inter-segment |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
39,939
|
41,230
|
52,285
|
Upstream | Operating segments |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Third-party and inter-segment purchases (CCS basis) |
7,368
|
7,890
|
10,666
|
Total expenditure |
9,790
|
9,830
|
10,321
|
Production and manufacturing expenses |
9,351
|
9,186
|
9,676
|
Selling, distribution and administrative expenses |
176
|
326
|
327
|
Research and development expenses |
263
|
318
|
318
|
Exploration expenses |
1,997
|
1,534
|
1,472
|
Depreciation, depletion and amortisation charge, of which: |
11,223
|
12,463
|
10,334
|
Impairment losses |
327
|
1,360
|
950
|
Impairment reversals |
(75)
|
(206)
|
(2,504)
|
Interest expense |
806
|
507
|
345
|
Marketing |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
120,089
|
130,559
|
149,439
|
Share of profit/(loss) of joint ventures and associates (CCS basis) |
6
|
561
|
249
|
Interest and other income, of which: |
(432)
|
73
|
(82)
|
Interest income |
1
|
9
|
0
|
Net (losses)/gains on sale and revaluation of non-current assets and businesses |
(399)
|
1
|
(169)
|
Other |
(34)
|
63
|
87
|
Taxation charge/(credit) (CCS basis) |
894
|
851
|
918
|
Marketing | CCS earnings |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
CCS earnings |
1,894
|
3,057
|
2,292
|
Marketing | CCS earnings | Revision of prior period, reclassification, adjustment |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
CCS earnings |
|
104
|
158
|
Marketing | Inter-segment |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
4,938
|
5,299
|
6,195
|
Marketing | Operating segments |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Third-party and inter-segment purchases (CCS basis) |
107,210
|
118,912
|
140,368
|
Total expenditure |
10,681
|
11,142
|
10,149
|
Production and manufacturing expenses |
1,322
|
1,463
|
1,293
|
Selling, distribution and administrative expenses |
9,150
|
9,427
|
8,631
|
Research and development expenses |
209
|
252
|
225
|
Exploration expenses |
0
|
0
|
0
|
Depreciation, depletion and amortisation charge, of which: |
3,866
|
2,477
|
2,027
|
Impairment losses |
1,633
|
430
|
479
|
Impairment reversals |
(1)
|
(1)
|
(151)
|
Interest expense |
56
|
53
|
47
|
Chemicals and Products |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
90,918
|
97,080
|
115,541
|
Share of profit/(loss) of joint ventures and associates (CCS basis) |
648
|
577
|
362
|
Interest and other income, of which: |
121
|
64
|
222
|
Interest income |
79
|
57
|
24
|
Net (losses)/gains on sale and revaluation of non-current assets and businesses |
6
|
(46)
|
265
|
Other |
36
|
53
|
(67)
|
Taxation charge/(credit) (CCS basis) |
177
|
(210)
|
928
|
Impairment losses on property, plant and equipment |
|
|
257
|
Reversal of impairment loss recognised in profit or loss, property, plant and equipment |
114
|
|
|
Chemicals and Products | CCS earnings |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
CCS earnings |
1,757
|
1,482
|
4,380
|
Chemicals and Products | CCS earnings | Revision of prior period, reclassification, adjustment |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
CCS earnings |
|
(104)
|
(158)
|
Chemicals and Products | Inter-segment |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
38,381
|
42,816
|
48,999
|
Chemicals and Products | Operating segments |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Third-party and inter-segment purchases (CCS basis) |
114,972
|
123,337
|
147,069
|
Total expenditure |
8,392
|
9,598
|
9,564
|
Production and manufacturing expenses |
6,605
|
7,394
|
7,100
|
Selling, distribution and administrative expenses |
1,636
|
2,022
|
2,303
|
Research and development expenses |
151
|
182
|
161
|
Exploration expenses |
0
|
0
|
0
|
Depreciation, depletion and amortisation charge, of which: |
4,700
|
6,269
|
3,162
|
Impairment losses |
1,319
|
2,777
|
357
|
Impairment reversals |
(114)
|
(90)
|
(73)
|
Interest expense |
70
|
61
|
21
|
Renewables and Energy Solutions |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
29,366
|
44,819
|
53,190
|
Share of profit/(loss) of joint ventures and associates (CCS basis) |
(807)
|
(96)
|
(7)
|
Interest and other income, of which: |
242
|
75
|
57
|
Interest income |
2
|
12
|
(2)
|
Net (losses)/gains on sale and revaluation of non-current assets and businesses |
119
|
110
|
8
|
Other |
121
|
(47)
|
51
|
Taxation charge/(credit) (CCS basis) |
99
|
1,320
|
(292)
|
Reversal of impairment loss recognised in profit or loss, property, plant and equipment |
134
|
|
|
Renewables and Energy Solutions | CCS earnings |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
CCS earnings |
(1,229)
|
3,089
|
(1,027)
|
Renewables and Energy Solutions | Inter-segment |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
4,971
|
4,707
|
6,791
|
Renewables and Energy Solutions | Operating segments |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Third-party and inter-segment purchases (CCS basis) |
31,074
|
40,170
|
57,024
|
Total expenditure |
2,915
|
3,763
|
3,547
|
Production and manufacturing expenses |
1,934
|
2,610
|
2,520
|
Selling, distribution and administrative expenses |
887
|
1,058
|
972
|
Research and development expenses |
94
|
95
|
55
|
Exploration expenses |
0
|
0
|
0
|
Depreciation, depletion and amortisation charge, of which: |
907
|
1,159
|
777
|
Impairment losses |
658
|
908
|
412
|
Impairment reversals |
(134)
|
(141)
|
0
|
Interest expense |
6
|
4
|
2
|
Corporate |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
43
|
42
|
41
|
Share of profit/(loss) of joint ventures and associates (CCS basis) |
0
|
(3)
|
(4)
|
Interest and other income, of which: |
1,136
|
1,818
|
706
|
Interest income |
2,264
|
2,202
|
959
|
Net (losses)/gains on sale and revaluation of non-current assets and businesses |
(3)
|
5
|
0
|
Other |
(1,125)
|
(389)
|
(253)
|
Taxation charge/(credit) (CCS basis) |
(209)
|
47
|
(36)
|
Corporate | CCS earnings |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
CCS earnings |
(2,992)
|
(2,944)
|
(2,562)
|
Corporate | Inter-segment |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
0
|
0
|
0
|
Corporate | Operating segments |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Third-party and inter-segment purchases (CCS basis) |
(3)
|
15
|
(28)
|
Total expenditure |
697
|
818
|
669
|
Production and manufacturing expenses |
14
|
58
|
22
|
Selling, distribution and administrative expenses |
426
|
446
|
443
|
Research and development expenses |
257
|
314
|
204
|
Exploration expenses |
0
|
0
|
0
|
Depreciation, depletion and amortisation charge, of which: |
26
|
19
|
18
|
Impairment losses |
1
|
0
|
0
|
Impairment reversals |
0
|
0
|
0
|
Interest expense |
$ 3,660
|
3,902
|
2,682
|
Corporate1 | CCS earnings | Revision of prior period, reclassification, adjustment |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
CCS earnings |
|
$ 133
|
$ 101
|